LIFEPOINT HEALTH, INC.Lifepoint Health, Inc. • November 24th, 2015 • Services-general medical & surgical hospitals, nec • New York
LIFEPOINT HEALTH, INC., a corporation organized under the laws of Delaware (the “Issuer”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the principal amount of its securities identified in Schedule II hereto (the “Securities” or the “Notes”), to be issued under an indenture (the “Base Indenture”) to be dated as of the Closing Date (as defined below), among the Issuer, the Guarantors (as defined below) and The Bank of New York Mellon, as trustee (the “Trustee”), as supplemented by a supplemental indenture (the “First Supplemental Indenture”), dated as of the Closing Date, by and among the Issuer, the Trustee and the Guarantors. As used herein, the term “Indenture” shall mean the Base Indenture, as supplemented by the First Supplemental Indenture. To the extent there are no additional Underwriters listed on Schedule II other than you, the term Representatives as used here
